Prot #VX24-548-110: A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects with Pain Associated with Diabetic Peripheral Neuropathy

Project: Research project

Project Details

StatusActive
Effective start/end date12/13/2412/13/27

Funding

  • Vertex Pharmaceuticals Incorporated (Prot #VX24-548-110)